Tertiary cytoreduction for recurrent ovarian carcinoma: an updated and expanded analysis

OBJECTIVE: We sought to describe clinicopathologic and surgical factors associated with oncologic outcomes in patients undergoing tertiary cytoreduction and to present a clinical model to identify patients with high-grade serous ovarian cancer (HGSOC) who may benefit most from tertiary cytoreduction...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Gynecol Oncol
Egile Nagusiak: Manning-Geist, Beryl L, Chi, Dennis S, Roche, Kara Long, Zivanovic, Oliver, Sonoda, Yukio, Gardner, Ginger J, O’Cearbhaill, Roisin E, Abu-Rustum, Nadeem R, Leitao, Mario M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8319116/
https://ncbi.nlm.nih.gov/pubmed/34045053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2021.05.015
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak